Lilly Walks Away As Roche Dominates EU’s COVID-19 Antibody Market
Sales Dwindled After Delta Fears
Still going strong in the US, Lilly has lost out to Roche’s Ronapreve in the European Union.
Still going strong in the US, Lilly has lost out to Roche’s Ronapreve in the European Union.